COURTNEY REID: Open Payments
NPI 1932981610 · HAMMOND, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$566 in 30 payments from 17 companies in 2025. Trend: 2023 $34 · 2024 $344 · 2025 $566
Food & beverage: $566
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $138 |
| Lilly USA, LLC | 4 | $67 |
| Radius Health, Inc. | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
| Alexion Pharmaceuticals, Inc. | 1 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $31 |
| Dexcom, Inc. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: MOUNJARO, VRAYLAR, CREON, Tymlos, Kerendia, STRENSIQ, XIFAXAN, CRENESSITY.
Industry payments across LA — which companies pay providers there.
